Innovation-Driven API Pipeline
Aizant is focused on the R&D and technology transfer of both Generic and Branded APIs, including high-value, low-volume and low-cost, high-volume APIs. While we do not currently offer commercial API manufacturing, our API development pipeline reflects our commitment to scientific rigor, safety, and digital innovation.
Therapeutic Categories Covered
- Oncology
- Central Nervous System (CNS)
- Metabolic & Endocrine Disorders
- Cardiovascular & Renal
- Anti-infectives & Anti-virals
- Respiratory & Inflammatory Diseases
Representative Capabilities
- Complex multi-step API synthesis
- Oncology APIs with cytotoxic handling
- NCEs and targeted generic APIs
- API route design backed by in-house IPM cell
Custom Requests
Looking for a specific molecule or development capability? We welcome collaborations to co-develop APIs in line with your project goals. Contact our scientific team to learn more about our API pipeline and customized R&D solutions.
